Stratec Biomedical AG Share Price Xetra
Equities
DE0007289001
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
04-26 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating | ZD |
04-26 | STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research remains Neutral | ZD |
Sales 2024 * | 276M 295M 23.6B | Sales 2025 * | 297M 317M 25.4B | Capitalization | 506M 541M 43.35B |
---|---|---|---|---|---|
Net income 2024 * | 19M 20.32M 1.63B | Net income 2025 * | 25M 26.73M 2.14B | EV / Sales 2024 * | 2.33 x |
Net Debt 2024 * | 137M 147M 11.73B | Net Debt 2025 * | 75.66M 80.89M 6.48B | EV / Sales 2025 * | 1.96 x |
P/E ratio 2024 * |
25.4
x | P/E ratio 2025 * |
19.6
x | Employees | - |
Yield 2024 * |
2.31% | Yield 2025 * |
2.18% | Free-Float | 59.43% |
Latest transcript on Stratec Biomedical AG
Managers | Title | Age | Since |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 56 | 28/02/98 |
Robert Siegle
DFI | Director of Finance/CFO | 56 | 30/04/98 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 57 | 28/05/19 |
Georg Heni
CHM | Chairman | 66 | 19/05/22 |
Rolf Vornhagen
BRD | Director/Board Member | 70 | 20/07/20 |
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |